Products & Ingredients

Unigen, Lehvoss Introduce Joint and Cartilage Support Formula

The new ingredient combines Univestin and Amlexin, two botanical ingredients that work synergistically to support joint comfort and function.

Author Image

By: Mike Montemarano

Associate Editor, Nutraceuticals World

Photo: bannafarsai | Adobe Stock

Ingredient developer Unigen and distributor Lehvoss Nutrition have launched a new combination formula featuring Univestin and Amlexin, branded extracts of Sutellaria baicalensis, Morus alba, and Acacia catechu, to the EU joint health market.

The combination formula is sold in the U.S. and other markets under the brand name Arthrolexin. In Europe, Lehvoss will sell the ingredient as Univestin + Amlexin.

Univestin contains bioflavonoids from Scutellaria baicalensis and heartwood of Acacia catechu, and promotes joint flexibility, joint comfort, and range of motion and physical function within days, according to clinical research.

Amlexin combines the root bark of Morus alba and the heartwood of Acacia catechu, and may help protect joints from wear and tear. According to studies, it can significantly reduce uCTX-II, a biomarker of joint cartilage breakdown.

Clinical research suggests that the two ingredients exhibit synergistic effects on joint health, helping to reduce joint discomfort, enhance flexibility, and support the preservation of articular cartilage matrix integrity composition, the companies noted.

“Unigen is a leading natural product research institute,” said Qi Jia, PhD, chief scientific officer at Unigen. “We have introduced two generations of joint care ingredients separately as Univestin and AmLexin from mechanism of action-based screening through our PhytoLogix library of medicinal plants. Univestin is the first generation of joint care ingredients patented by Unigen, targeting fast and long-lasting symptom relief. Amlexin is a symptom-modifying natural active protecting cartilage from wear and tear and slowing down the catabolic process.”

“The results of this combination study and individual studies on both ingredients confirm that Univestin and Amlexin are certainly an alternative, innovative, plant-based solution for the European market, not only for OA management, but also for active lifestyle support,” said Teresita Rudà, head of marketing and brand positioning at Lehvoss Nutrition.

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters